- Poland
- /
- Healthcare Services
- /
- WSE:VOX
Undiscovered Gems in Europe to Explore This July 2026
As the European market navigates a period of volatility, with the pan-European STOXX Europe 600 Index showing little change amid tech sector weakness and geopolitical tensions, investors are keenly observing economic indicators such as inflation rates and industrial production figures. In this environment, identifying stocks that possess strong fundamentals and resilience to broader market fluctuations can be particularly rewarding for those exploring potential opportunities in Europe's diverse landscape.
Top 10 Undiscovered Gems With Strong Fundamentals In Europe
| Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
|---|---|---|---|---|
| Zinzino | NA | 21.79% | 32.66% | ★★★★★★ |
| C-Rad | NA | 13.57% | 13.83% | ★★★★★★ |
| GROUPE SFPI | 18.02% | 4.25% | -29.76% | ★★★★★★ |
| Angler Gaming | NA | -5.12% | -24.26% | ★★★★★★ |
| IDI | 2.16% | -16.11% | -24.28% | ★★★★★☆ |
| VBG Group | 41.41% | 9.00% | 6.26% | ★★★★★☆ |
| Edel SE KGaA | 142.35% | 1.36% | 12.24% | ★★★★☆☆ |
| Bokusgruppen | 25.20% | 3.74% | 19.78% | ★★★★☆☆ |
| SP Group | 85.48% | 5.03% | 8.16% | ★★★★☆☆ |
| Jæren Sparebank | 167.99% | 11.94% | 17.71% | ★★★☆☆☆ |
Here we highlight a subset of our preferred stocks from the screener.
Angler Gaming (DB:0QM)
Simply Wall St Value Rating: ★★★★★★
Overview: Angler Gaming plc is a company that invests in online gaming service providers based in Malta, with a market capitalization of €313.44 million.
Operations: Angler Gaming generates revenue primarily from iGaming activities, totaling €30.69 million. The company's net profit margin is a key financial metric to consider when evaluating its profitability.
Angler Gaming, a nimble player in the European gaming sector, is making waves with its impressive earnings growth. The company reported a 154.4% increase in earnings over the past year, outpacing the Hospitality industry's 71.9% rise. Trading at an attractive 88.3% below estimated fair value, Angler seems to offer good relative value compared to peers and industry standards. With no debt on its books and strong non-cash earnings quality, Angler's financial health appears robust. Recent results show net income climbing to €2.52 million for Q1 2026 from €1.36 million last year, highlighting its potential for continued growth.
- Take a closer look at Angler Gaming's potential here in our health report.
Evaluate Angler Gaming's historical performance by accessing our past performance report.
RaySearch Laboratories (OM:RAY B)
Simply Wall St Value Rating: ★★★★★★
Overview: RaySearch Laboratories AB (publ) is a medical technology company that offers software solutions for cancer treatment on a global scale, with a market cap of SEK5.64 billion.
Operations: The company generates revenue primarily from its healthcare software segment, amounting to SEK1.30 billion.
RaySearch Laboratories, a nimble player in the medical technology space, is making strides with its innovative cancer treatment software. Despite recent volatility in share price, the company trades at 57.8% below its estimated fair value and boasts no debt—a significant improvement from a 12.1% debt to equity ratio five years ago. Earnings have surged by an impressive 63.8% annually over the past five years, although recent growth of 0.3% lagged behind industry peers at 0.6%. With high-quality earnings and strong free cash flow of SEK 276 million as of September 2024, RaySearch seems well-positioned for future expansion amidst global demand for AI-enhanced oncology solutions.
Voxel (WSE:VOX)
Simply Wall St Value Rating: ★★★★★★
Overview: Voxel S.A. operates in the healthcare sector, offering medical services in Poland, with a market capitalization of PLN 1.25 billion.
Operations: Voxel's revenue is primarily driven by its Diagnostics segment, which includes medical services and sales of radiopharmaceuticals, generating PLN 451.79 million. The IT & Infrastructure segment contributes PLN 142.54 million through IT products and laboratory equipment sales. Therapy - Neuroradiosurgery adds PLN 15.70 million to the overall revenue stream.
Voxel S.A., a notable player in the healthcare sector, showcases promising financials with earnings growing 14.1% annually over the past five years. Despite recent quarterly sales of PLN 157.19 million, slightly down from PLN 157.85 million last year, net income rose to PLN 31.9 million from PLN 24.27 million, indicating robust profitability and high-quality earnings. The company is trading at a significant discount of 57% below its estimated fair value and maintains a satisfactory net debt to equity ratio of 12.1%. With EBIT covering interest payments by an impressive margin of 17 times, Voxel's financial health appears strong as it continues to trade at good value compared to industry peers.
- Navigate through the intricacies of Voxel with our comprehensive health report here.
Assess Voxel's past performance with our detailed historical performance reports.
Where To Now?
- Discover the full array of 41 European Undiscovered Gems With Strong Fundamentals right here.
- Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
- Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.
Ready For A Different Approach?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
mitchell_lawlerMicron (MU) is booming, and it still doesn't look ‘expensive’ based on next year's earnings. So why does our own valuation say it could be worth 40% less?
A low price to earnings ratio at the top of the cycle is a warning rather than a bargain, and a terrifyingly high one at the bottom is often the entry point
Memory used to have a dozen participants racing each other into oversupply, and now it has three. High bandwidth memory is qualified into customer designs years ahead, sold under long-term agreements, and is far harder to switch away from than commodity DRAM.
About WSE:VOX
Voxel
Provides medical services in Poland.
Flawless balance sheet and undervalued.
Similar Companies
Market Insights
Weekly Picks

The 1960s Fighter Jet That Could Crack Open a $20 Billion Satellite Market

The Short and Long Term Compounder of Liquid Cooling industry.

I Fell in Love With a Data-Center Cooling Stock. Then I Opened the Filings.

The Cheap Genius Problem
Recently Updated Narratives

Why Bancolombia’s undervaluation offers investment upside
LEAD: The Offshore Recovery Opportunity
Lotus Tech, Finloop and FOMO Pay Collaborate to Explore Vehicle Tokenization
Popular Narratives

